HK Stock Market Move | TIANLI HOLDINGS (00117) rose more than 23%, Samsung Motor's AI-MLCC long orders are about to land, industry price hikes are accelerating.
Tianli Holdings Group (00117) rose by more than 23% at one point, as of the time of writing, it has increased by 16.23% to 4.44 Hong Kong dollars, with a trading volume of 29.6071 million Hong Kong dollars.
TIANLI HOLDINGS (00117) once rose by more than 23%, and as of the time of writing, it has risen by 16.23%, reaching 4.44 Hong Kong dollars, with a turnover of 2960.71 million Hong Kong dollars.
On the news front, it is reported that Samsung Motors is in final negotiations with an American cloud service provider on a supply contract for multi-layer ceramic capacitors (MLCC) for artificial intelligence servers. The contract is estimated to be around 500 billion Korean won. It is worth mentioning that the MLCC spot market has been hot since the beginning of 2026, with further heating up since May, and some scarce part numbers have seen multiple price increases.
TIANLI HOLDINGS is a holding company mainly engaged in the ceramic capacitor business. The annual report for 2025 shows that the company's MLCC revenue was 639 million RMB last year, with a gross profit margin increasing to 21.2%. CITIC SEC noted that they have observed a recent MLCC industry price hike, believing that this round of the MLCC cycle is expected to be similar to the super boom period of 2017-2018, with the price hike expected to last for over a year, and the price increase at the original factory end is expected to achieve a significant increase of double or even higher.
Related Articles

HK Stock Market Move | HENLIUS (02696) rose more than 13% in early trading. H Medicine has been approved for a new indication in the European Union, achieving full coverage of first-line treatment for core subtypes of lung cancer.

Orient: Foreign cosmetics market warms up while domestic products break through, the entire industry is moving towards a high-quality "value war."
HK Stock Market Move | CSPC PHARMA (01093) rose nearly 9%, SYS6010-022 has officially launched in China and plans to complete the enrollment of the first subject in July.
HK Stock Market Move | HENLIUS (02696) rose more than 13% in early trading. H Medicine has been approved for a new indication in the European Union, achieving full coverage of first-line treatment for core subtypes of lung cancer.

Orient: Foreign cosmetics market warms up while domestic products break through, the entire industry is moving towards a high-quality "value war."

HK Stock Market Move | CSPC PHARMA (01093) rose nearly 9%, SYS6010-022 has officially launched in China and plans to complete the enrollment of the first subject in July.
RECOMMEND





